Ensign Peak Advisors, Inc Amicus Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 98,806 shares of FOLD stock, worth $986,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares

98,806

Previous 98,806 -0.0%

Holding current value

$986,083

Previous $980,000 7.65%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$11.43 - $14.24 $56,967 - $70,972	-4,984 Reduced 4.8%	98,806 $1.16 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $46,096 - $57,190	4,300 Added 4.32%	103,790 $1.3 Million
Q4 2022 Feb 13, 2023	BUY	$9.89 - $12.7 $427,248 - $548,640	43,200 Added 76.75%	99,490 $1.21 Million
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $1.74 Million - $2.26 Million	-177,269 Reduced 75.9%	56,290 $588,000
Q2 2022 Aug 12, 2022	BUY	$6.23 - $11.12 $1.11 Million - $1.97 Million	177,429 Added 316.1%	233,559 $2.51 Million
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $79,925 - $126,422	10,130 Added 22.02%	56,130 $532,000
Q4 2021 Feb 11, 2022	BUY	$9.82 - $12.44 $451,720 - $572,240	46,000 New	46,000 $531,000
Q1 2021 May 12, 2021	SELL	$9.2 - $23.86 $1.08 Million - $2.8 Million	-117,502 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $169,789 - $313,738	-12,605 Reduced 9.69%	117,502 $2.71 Million
Q3 2020 Nov 12, 2020	BUY	$12.89 - $15.89 $1.6 Million - $1.97 Million	124,019 Added 2037.11%	130,107 $1.84 Million
Q1 2020 May 11, 2020	SELL	$6.63 - $11.16 $47,000 - $79,113	-7,089 Reduced 53.8%	6,088 $56,000
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $98,563 - $141,652	13,177 New	13,177 $129,000

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.8B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Amicus Therapeutics, Inc. Transaction History